Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 13 OCTOBER 2025

Update To California Hemp Laws

Buchanan Ingersoll & Rooney
Explore more from Buchanan Ingersoll & Rooney

As we previously advised you, on October 2, California Governor Gavin Newsom signed AB-8 and issued a press release touting he signed "legislation to regulate intoxicating hemp products...

United StatesCannabis & Hemp
Daniel P. McGee
Daniel P. McGee
Author LinkedIn connections

As we previously advised you, on October 2, California Governor Gavin Newsom signed AB-8 and issued a press release touting he signed "legislation to regulate intoxicating hemp products and give government agencies tools to stop illegal sales". AB-8 outlaws synthetic cannabis products and inhalable cannabis products containing cannabinoids derived from hemp. The California Assembly voted, 73-1, to concur with Senate amendments on Sept. 13, after the upper chamber voted, 37-0, the previous day to pass the bill.

Per Assembly Majority Leader Aguiar-Curry (D-Winters), "[b]ad actors have abused state and federal law to sell intoxicating hemp products in our State. As the author of legislation that allowed the legal sale of non-intoxicating hemp CBD products, this is absolutely unacceptable," She also emphasized, "[o]ur first job is to protect our kids and our communities. With this bill, we'll have responsible regulation, increase enforcement, and support struggling

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

The Intoxicating Hemp Products Ban Was Delayed A Month. Now What?

The House has passed a short-term funding bill postponing the federal ban on hemp-derived THC products from November 12th to December 11th. With comprehensive legislation unlikely before the new deadline and competing interests from cannabis sellers, alcohol producers, and state regulators creating policy gridlock, the future of intoxicating hemp products remains uncertain as midterm elections approach.
United StatesCannabis & Hemp
Harris Sliwoski
Harris Sliwoski
Article

IRC Section 280E And Cannabis Tax Planning: Recent Developments And Practical Considerations

The landscape surrounding Section 280E of the Internal Revenue Code continues to evolve with President Trump's Executive Order on medical marijuana rescheduling, advancing litigation in New Mexico Top Organics v. Commissioner, and shifting regulatory signals. Cannabis taxpayers face critical decisions about taking "non-280E" positions on their tax returns while the IRS maintains its enforcement stance and the U.S. Tax Court case addressing common arguments remains pending.
United StatesCannabis & Hemp
Foley Hoag LLP
Foley Hoag LLP
Article

Tenth Circuit Stays Nationwide Eligibility Injunction For Class Of 2022 In Wisne v. NCAA

On August 21, 2026, the Tenth Circuit granted the NCAA’s stay request in Wisne v. NCAA, temporarily restoring the NCAA’s age-based eligibility rules pending resolution of the appeal. Three weeks earlier, Judge Sweeney of the District of Colorado had issued a nationwide injunction that permitted athletes in the Class of 2022 to pursue a fifth year of eligibility.
United StatesLitigation, Mediation & Arbitration
Buchanan Ingersoll & Rooney
Buchanan Ingersoll & Rooney
Article

Allegheny County Council Passes Paid Parental Leave Policy

On Tuesday, October 20, 2026, the Allegheny County Council passed legislation requiring employers with at least 15 workers to provide 12 weeks of paid parental leave, ending months-long debate on the proposal. We previously reported on the initial 18-week proposal in May 2026 (summarized here), the revised proposed legislation (summarized here), and the Allegheny County Board of Health passing the legislation (summarized here). The measure was passed in an 11-4 vote. It will become effective in one year, as County Executive Sara Innamorato signed the bill on, October 22, 2026.
United StatesEmployment and HR
Buchanan Ingersoll & Rooney
Buchanan Ingersoll & Rooney
Article

NCAA Enjoined From Enforcing New Fifth-Year Eligibility Rule

A federal court has issued a nationwide injunction blocking the NCAA from enforcing its new five-year eligibility rule against Division I athletes who graduated high school in 2022. The ruling creates immediate compliance challenges for athletic departments as they navigate roster management, revenue-sharing caps, and potential penalties while the NCAA appeals the decision.
United StatesConsumer Protection
Buchanan Ingersoll & Rooney
Buchanan Ingersoll & Rooney
Article

Update On CAPE Phase 3 Duty Refunds From U.S. Customs And Border Protection

U.S. Customs and Border Protection has announced that importers with court orders for IEEPA duty refunds on finally liquidated entries can begin filing for those refunds starting October 6, 2026, through the CAPE Phase 3 system. This development follows the Supreme Court's February 2026 decision striking down IEEPA tariffs and represents a critical step for importers seeking refunds on entries liquidated for more than 80 days.
United StatesInternational Law
Buchanan Ingersoll & Rooney
Buchanan Ingersoll & Rooney
Article

Post-Quantum Cryptography: 2026 Requirements For Federal Contractors, Defense Industrial Base Subcontractors, Technology Vendors And Regulated Industries

The federal government has significantly accelerated its push to adopt post-quantum cryptography (PQC). Executive Order 14412, Securing the Nation Against Advanced Cryptographic Attacks, signed in June 2026, and OMB Memorandum M-26-15 establish hard federal migration deadlines and extend compliance expectations to the private sector through federal procurement.
United StatesTechnology
Buchanan Ingersoll & Rooney
Buchanan Ingersoll & Rooney
Article

Defense Counterintelligence And Security Agency Report Reveals Threats To U.S. Cleared Industry

The Defense Counterintelligence and Security Agency has released its 2026 annual report revealing alarming trends in foreign exploitation of U.S. cleared contractors and sensitive technologies. With over 22,000 suspicious contact reports and 2,900 identified incidents in FY 2025, the report exposes how foreign entities systematically target subject matter experts and leverage cyber operations to access classified information. The analysis highlights critical shifts in threat patterns, communication methods,
United StatesGovernment, Public Sector
Buchanan Ingersoll & Rooney
Buchanan Ingersoll & Rooney
Article

Proposed IRS And Treasury Rules Tie Racial Nondiscrimination To Tax-Exempt Status For Private Schools And Universities

On September 3, 2026, the U.S. Department of the Treasury and the Internal Revenue Service (IRS) issued proposed regulations under Section 501(c)(3) that could materially affect private education in the United States. The proposal would apply a broad nondiscrimination standard based on race, color and national or ethnic origin, with significant implications for private schools, colleges and universities seeking or maintaining tax-exempt status under Section 501(c)(3).
United StatesTax
Buchanan Ingersoll & Rooney
Buchanan Ingersoll & Rooney
Article

The House Energy And Commerce Committee’s Fraud Report And The Direction Of Health Care Enforcement

A House Committee staff report proposes shifting federal health care programs from a "pay and chase" to a "detect and prevent" fraud model, identifying high-risk service lines and recommending expanded enforcement authority for CMS. The report examines case examples involving pharmacies, telemedicine platforms, and multi-state schemes, while acknowledging that improper payments encompass a spectrum from documentation errors to deliberate billing fraud.
United StatesFood, Drugs, Healthcare, Life Sciences
Buchanan Ingersoll & Rooney
Buchanan Ingersoll & Rooney